Idera Pharmaceuticals, Inc.

NASDAQ:IDRA   3:55:52 PM EDT
0.63
+0.04 (+6.26%)
Earnings Announcements

Idera Pharmaceuticals Reports First Quarter 2022 Financial Results

Published: 05/05/2022 20:55 GMT
Idera Pharmaceuticals, Inc. (IDRA) - Idera Pharmaceuticals Reports First Quarter 2022 Financial Results and Provides Corporate Update.
Q1 Loss per Share $0.08.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.11

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.11

More details on our Analysts Page.